Nature editorial urges rigor as personalized care and psychedelics reshape psychiatry
A Nature editorial, drawing on two accompanying news features, highlights emerging efforts to personalize mental-health treatment and develop psychedelic therapies as potential responses to a global mental-health crisis affecting over a billion people. The editorial notes the FDA has recently clarified evidence standards expected in psychedelic drug trials ahead of possible regulatory approval.